Company / Return on Assets (ROA)
Vaxcyte, Inc. Return on Assets (ROA) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-25.5%
FY2025
5-year range
-30.9% / -13.2%
FY2021-FY2025
Trend
-93.3%
vs FY2024
Sector context
#115 of 213
Health Care
What the data says
At -25.5%, Vaxcyte, Inc.'s return on assets (roa) ranks #115 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 7 years, ranging from -76.5% in FY2019 to -13.2% in FY2024.
Based on SEC 10-K filings.
-25.5% in FY2025 with a 5-year CAGR of -2.8%.
Improved from -28.6% to -25.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -3.3pp
- 5-Year Change
- -2.8pp
- 10-Year Change
- -
Sector benchmark
#115 of 213 in Health CareTop 54% of 213This company -25.5% Sector average -24.1%
▼
-5.8% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 93.3% year-over-year.
- Currently 1.4pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -25.5% | -93.3% |
| FY2024 | -13.2% | +53.8% |
| FY2023 | -28.6% | -28.6% |
| FY2022 | -22.2% | +28.0% |
| FY2021 | -30.9% | -35.9% |
| FY2020 | -22.7% | +70.3% |
| FY2019 | -76.5% | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026